Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 16-Aug-22 6:54 PM View:  | Kutok Jeffery Chief Scientific Officer | Epizyme, Inc. (EPZM) | 12-Aug-22 | Disposition | 120,067 | -- | -- | (100%) 120.07K to 0 | |
| 16-Aug-22 6:55 PM View: | Bate Kenneth Director | Epizyme, Inc. (EPZM) | 12-Aug-22 | Disposition | 17,054 | -- | -- | (100%) 17.05K to 0 | |
| 16-Aug-22 6:54 PM View: | Stuckley Carol Director | Epizyme, Inc. (EPZM) | 12-Aug-22 | Disposition | 25,696 | -- | -- | (100%) 25.7K to 0 | |
| 16-Aug-22 6:59 PM View: | Mott David M Director | Epizyme, Inc. (EPZM) | 12-Aug-22 | Disposition (change in control) | 215,494 | -- | -- | (67%) 322.45K to 106.96K | |
| 16-Aug-22 6:59 PM View: | Richon Victoria Director | Epizyme, Inc. (EPZM) | 12-Aug-22 | Disposition | 22,608 | -- | -- | (100%) 22.61K to 0 | |
| 16-Aug-22 7:02 PM View: | Goldfischer Carl Director | Epizyme, Inc. (EPZM) | 12-Aug-22 | Disposition | 3,380,950 | -- | -- | (100%) 3.38M to 0 | |
| 16-Aug-22 6:59 PM View: | Mott David M Director | Epizyme, Inc. (EPZM) | 12-Aug-22 | Disposition (change in control) | 106,959 | -- | -- | (100%) 106.96K to 0 | |
| 16-Aug-22 7:03 PM View: | Giordano Michael F Director | Epizyme, Inc. (EPZM) | 12-Aug-22 | Disposition | 17,054 | -- | -- | (100%) 17.05K to 0 | |
| 16-Aug-22 6:55 PM View: | Legorreta Pablo G. Director 10% Owner | Epizyme, Inc. (EPZM) | 12-Aug-22 | Disposition (change in control) | 31,933,300 | -- | -- | (100%) 31.93M to 0 | |
| 16-Aug-22 6:55 PM View: | Beaulieu Joseph See Remarks | Epizyme, Inc. (EPZM) | 12-Aug-22 | Disposition | 52,076 | -- | -- | (100%) 52.08K to 0 | |
| 16-Aug-22 6:57 PM View: | Agarwal Shefali | Epizyme, Inc. (EPZM) | 12-Aug-22 | Disposition | 286,539 | -- | -- | (100%) 286.54K to 0 | |
| 16-Aug-22 6:52 PM View: | Bogle Grant C. President and CEO Director | Epizyme, Inc. (EPZM) | 12-Aug-22 | Disposition | 259,170 | -- | -- | (100%) 259.17K to 0 | |
| 16-Aug-22 6:59 PM View: | Mott David M Director | Epizyme, Inc. (EPZM) | 12-Aug-22 | Disposition | 8,994 | -- | -- | (3%) 331.45K to 322.45K | |
| 16-Aug-22 7:02 PM View: | Conroy Kevin T Director | Epizyme, Inc. (EPZM) | 12-Aug-22 | Disposition | 62,318 | -- | -- | (100%) 62.32K to 0 | |
| 16-Aug-22 6:58 PM View: | Beveridge, Roy A Director | Epizyme, Inc. (EPZM) | 12-Aug-22 | Disposition | 46,037 | -- | -- | (100%) 46.04K to 0 | |
| 16-Aug-22 7:02 PM View: | Goldfischer Carl Director | Epizyme, Inc. (EPZM) | 12-Aug-22 | Disposition | 22,054 | -- | -- | (< 1%) 3.4M to 3.38M | |
| 11-Aug-22 8:53 PM View: | Beaulieu Joseph See Remarks | Epizyme, Inc. (EPZM) | 09-Aug-22 | Payment of Exercise | 279,864 | $1.39 | $389,011.00 | (85%) 330.96K to 51.1K | |
| 11-Aug-22 8:53 PM View: | Agarwal Shefali | Epizyme, Inc. (EPZM) | 09-Aug-22 | Payment of Exercise | 373,154 | $1.39 | $518,684.00 | (57%) 658.72K to 285.56K | |
| 11-Aug-22 9:00 PM View: | Bogle Grant C. See Remarks Director | Epizyme, Inc. (EPZM) | 09-Aug-22 | Option Exercise | 1,217,500 | $1.40 | $1,700,680.00 | 665% 183.06K to 1.4M | |
| 11-Aug-22 8:53 PM View: | Beaulieu Joseph See Remarks | Epizyme, Inc. (EPZM) | 09-Aug-22 | Option Exercise | 300,000 | $1.39 | $417,000.00 | 969% 30.96K to 330.96K | |
| 11-Aug-22 8:53 PM View: | Agarwal Shefali | Epizyme, Inc. (EPZM) | 09-Aug-22 | Option Exercise | 500,000 | $1.39 | $695,000.00 | 315% 158.72K to 658.72K | |
| 11-Aug-22 8:52 PM View: | Kutok Jeffery Chief Scientific Officer | Epizyme, Inc. (EPZM) | 09-Aug-22 | Payment of Exercise | 354,496 | $1.39 | $492,749.00 | (75%) 474.56K to 120.07K | |
| 11-Aug-22 8:52 PM View: | Kutok Jeffery Chief Scientific Officer | Epizyme, Inc. (EPZM) | 09-Aug-22 | Option Exercise | 380,000 | $1.39 | $528,200.00 | 402% 94.56K to 474.56K | |
| 11-Aug-22 9:00 PM View: | Bogle Grant C. See Remarks Director | Epizyme, Inc. (EPZM) | 09-Aug-22 | Payment of Exercise | 1,141,390 | $1.40 | $1,594,430.00 | (81%) 1.4M to 259.17K | |
| 05-Jul-22 5:06 PM View: | Mott David M Director | Epizyme, Inc. (EPZM) | 30-Jun-22 | Grant | 16,156 | $1.47 | $23,749.30 | 5% 315.29K to 331.45K | |
| 05-Jul-22 5:02 PM View: | Conroy Kevin T Director | Epizyme, Inc. (EPZM) | 30-Jun-22 | Grant | 10,204 | $1.47 | $14,999.90 | 20% 52.11K to 62.32K | |
| 05-Jul-22 5:06 PM View: | Beveridge, Roy A Director | Epizyme, Inc. (EPZM) | 30-Jun-22 | Grant | 8,928 | $1.47 | $13,124.20 | 24% 37.11K to 46.04K | |
| 19-May-22 4:26 PM View: | Mott David M Director | Epizyme, Inc. (EPZM) | 17-May-22 | Grant | 8,994 | -- | -- | 3% 306.3K to 315.29K | |
| 19-May-22 4:26 PM View: | Conroy Kevin T Director | Epizyme, Inc. (EPZM) | 17-May-22 | Grant | 8,994 | -- | -- | 21% 43.12K to 52.11K | |
| 19-May-22 4:20 PM View: | Beveridge, Roy A Director | Epizyme, Inc. (EPZM) | 17-May-22 | Grant | 8,994 | -- | -- | 32% 28.11K to 37.11K | |
| 19-May-22 4:28 PM View: | Giordano Michael F Director | Epizyme, Inc. (EPZM) | 17-May-22 | Grant | 8,994 | -- | -- | 112% 8.06K to 17.05K | |
| 19-May-22 4:23 PM View: | Goldfischer Carl Director | Epizyme, Inc. (EPZM) | 17-May-22 | Grant | 8,994 | -- | -- | < 1% 3.39M to 3.4M | |
| 19-May-22 4:30 PM View: | Bate Kenneth Director | Epizyme, Inc. (EPZM) | 17-May-22 | Grant | 8,994 | -- | -- | 112% 8.06K to 17.05K | |
| 19-May-22 4:29 PM View: | Stuckley Carol Director | Epizyme, Inc. (EPZM) | 17-May-22 | Grant | 8,994 | -- | -- | 54% 16.7K to 25.7K | |
| 19-May-22 4:29 PM View: | Richon Victoria Director | Epizyme, Inc. (EPZM) | 17-May-22 | Grant | 8,994 | -- | -- | 66% 13.61K to 22.61K | |
| 13-Apr-22 5:49 PM View: | Kutok Jeffery Chief Scientific Officer | Epizyme, Inc. (EPZM) | 11-Apr-22 | Sale (Planned) | 2,741 | $0.90 | $2,466.90 | (3%) 97.3K to 94.56K | |
| 01-Apr-22 5:30 PM View: | Mott David M Director | Epizyme, Inc. (EPZM) | 31-Mar-22 | Grant | 20,653 | $1.15 | $23,750.90 | 7% 285.64K to 306.3K | |
| 01-Apr-22 5:30 PM View: | Conroy Kevin T Director | Epizyme, Inc. (EPZM) | 31-Mar-22 | Grant | 13,043 | $1.15 | $14,999.40 | 43% 30.08K to 43.12K | |
| 01-Apr-22 5:31 PM View: | Beveridge, Roy A Director | Epizyme, Inc. (EPZM) | 31-Mar-22 | Grant | 11,413 | $1.15 | $13,125.00 | 68% 16.7K to 28.11K | |
| 21-Mar-22 6:06 PM View: | Beaulieu Joseph See Remarks | Epizyme, Inc. (EPZM) | 28-Feb-22 | Grant | 2,331 | $1.27 | $2,952.21 | 8% 28.63K to 30.96K | |
| 21-Mar-22 6:05 PM View: | Agarwal Shefali See Remarks | Epizyme, Inc. (EPZM) | 28-Feb-22 | Grant | 2,331 | $1.27 | $2,952.21 | 1% 156.38K to 158.72K | |
| 09-Feb-22 5:40 PM View: | Agarwal Shefali See Remarks | Epizyme, Inc. (EPZM) | 07-Feb-22 | Sale (Planned) | 1,058 | $1.50 | $1,587.00 | (< 1%) 157.44K to 156.38K | |
| 09-Feb-22 5:43 PM View: | Beaulieu Joseph Corporate Controller | Epizyme, Inc. (EPZM) | 07-Feb-22 | Sale (Planned) | 222 | $1.50 | $333.00 | (< 1%) 28.85K to 28.63K | |
| 04-Feb-22 4:15 PM View: | Kutok Jeffery Chief Scientific Officer | Epizyme, Inc. (EPZM) | 02-Feb-22 | Sale (Planned) | 2,556 | $1.37 | $3,501.72 | (3%) 99.86K to 97.3K | |
| 04-Feb-22 4:15 PM View: | Bogle Grant C. See Remarks Director | Epizyme, Inc. (EPZM) | 02-Feb-22 | Grant | 87,500 | -- | -- | 92% 95.56K to 183.06K | |
| 04-Feb-22 4:15 PM View: | Beaulieu Joseph Corporate Controller | Epizyme, Inc. (EPZM) | 02-Feb-22 | Sale (Planned) | 687 | $1.37 | $941.19 | (2%) 29.54K to 28.85K | |
| 04-Feb-22 4:15 PM View: | Agarwal Shefali See Remarks | Epizyme, Inc. (EPZM) | 02-Feb-22 | Sale (Planned) | 2,639 | $1.37 | $3,615.43 | (2%) 160.08K to 157.44K | |
| 01-Feb-22 4:17 PM View: | Legorreta Pablo G. Director 10% Owner | Epizyme, Inc. (EPZM) | 31-Jan-22 | Private Purchase | 22,666,700 | $1.50 | $34,000,000.00 | 247% 9.17M to 31.83M | |
| 28-Jan-22 4:15 PM View: | Agarwal Shefali See Remarks | Epizyme, Inc. (EPZM) | 26-Jan-22 | Market Sale (Planned) | 2,922 | $2.02 | $5,902.44 | (2%) 163.0K to 160.08K | (19%) |
| 04-Jan-22 10:00 PM View: | Conroy Kevin T Director | Epizyme, Inc. (EPZM) | 31-Dec-21 | Grant | 6,000 | $2.50 | $15,000.00 | 25% 24.08K to 30.08K | (3%) |
